We are live on ! Find out more
BPC

Banque Pictet & Cie Portfolio holdings

AUM $16B
1-Year Est. Return 29.1%
This Fund
S&P 500
This Quarter Est. Return
+17.83%
1 Year Est. Return
+29.1%
3 Year Est. Return
+74.82%
5 Year Est. Return
+105.76%
10 Year Est. Return
+488.78%
AUM
$16B
AUM Growth
+$1.78B
Cap. Flow
+$33.6M
Cap. Flow %
0.21%
Top 10 Hldgs %
65.86%
Holding
407
New
22
Increased
83
Reduced
147
Closed
77

Top Buys

Rank Stock Value
1
MDLN
Medline Inc
MDLN
+$237M
2
MA icon
Mastercard
MA
+$117M
3
WSE
Wise Group
WSE
+$21.4M
4
TW icon
Tradeweb Markets
TW
+$19M
5
PH icon
Parker-Hannifin
PH
+$18.9M

Sector Composition

Rank Sector Weight
1 Technology 16.55%
2 Consumer Discretionary 10.11%
3 Healthcare 8.38%
4 Communication Services 8.16%
5 Financials 7.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DXCM icon
176
DexCom
DXCM
$33.1B
$2.81M 0.02%
41,734
-54,521
-57% -$3.63M
ACN icon
177
Accenture
ACN
$109B
$2.81M 0.02%
22,578
+4,250
+23% +$738K
UTHR icon
178
United Therapeutics
UTHR
$22.7B
$2.66M 0.02%
4,914
+383
+8% +$216K
XLE icon
179
State Street Energy Select Sector SPDR ETF
XLE
$39.3B
$2.65M 0.02%
49,900
-56,100
-53% -$3.21M
PCVX icon
180
Vaxcyte
PCVX
$8.67B
$2.6M 0.02%
44,736
-17,110
-28% -$929K
IRTC icon
181
iRhythm Holdings
IRTC
$4.11B
$2.6M 0.02%
21,841
-2,974
-12% -$346K
SIL icon
182
Global X Silver Miners ETF NEW
SIL
$4.83B
$2.4M 0.02%
31,000
BABA icon
183
Alibaba
BABA
$317B
$2.4M 0.02%
25,000
NTR icon
184
PUT
Nutrien
NTR
$31.6B
$2.38M 0.01%
37,806
+32,806
+656% +$2.29M
MSFT icon
185
CALL
Microsoft
MSFT
$3.76T
$2.33M 0.01%
+6,264
New +$2.53M
GPCR icon
186
Structure Therapeutics
GPCR
$3.82B
$2.33M 0.01%
43,332
-6,035
-12% -$267K
REGN icon
187
Regeneron Pharmaceuticals
REGN
$83.2B
$2.32M 0.01%
3,713
-6,180
-62% -$4.21M
RACE icon
188
Ferrari
RACE
$71.5B
$2.31M 0.01%
6,226
-1,591
-20% -$553K
BIDU icon
189
Baidu
BIDU
$37.1B
$2.29M 0.01%
20,000
ECL icon
190
Ecolab
ECL
$79.7B
$2.21M 0.01%
7,926
-323
-4% -$85.1K
IMVT icon
191
Immunovant
IMVT
$8.24B
$2.2M 0.01%
57,190
-31,470
-35% -$959K
NKE icon
192
Nike
NKE
$62.5B
$2.19M 0.01%
53,268
-33,700
-39% -$1.48M
ICLR icon
193
Icon
ICLR
$12.8B
$2.09M 0.01%
12,018
-1,220
-9% -$155K
EMFI
194
Pictet Emerging Markets Debt ETF
EMFI
$17.5M
$2.05M 0.01%
+40,530
New +$2.04M
QBTS icon
195
D-Wave Quantum Inc. Common Stock
QBTS
$7.52B
$2.04M 0.01%
85,000
PYLD icon
196
PIMCO Multi Sector Bond Active ETF
PYLD
$15.2B
$2M 0.01%
75,580
JMBS icon
197
Janus Henderson Mortgage-Backed Securities ETF
JMBS
$6.72B
$1.99M 0.01%
44,150
GMED icon
198
Globus Medical
GMED
$11.6B
$1.97M 0.01%
24,944
-2,583
-9% -$220K
RGTI icon
199
Rigetti Computing
RGTI
$5.89B
$1.93M 0.01%
100,000
EW icon
200
Edwards Lifesciences
EW
$53B
$1.92M 0.01%
21,262
-837
-4% -$70.1K

Similar funds

Banque Pictet & Cie's Q2 2026 Portfolio in Review

As of Q2 2026, Banque Pictet & Cie held 407 positions worth $16B, up 13% from $14.2B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Banque Pictet & Cie's Q2 2026 filing shows 22 new, 83 increased, 147 reduced and 77 closed positions. Its largest new stake was Wise Group: 1,795,190 shares worth $21.5M. The largest sale was Alphabet (Google) Class C, an estimated $96.4M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Banque Pictet & Cie's largest Q2 2026 buy was Wise Group: 1,795,190 shares worth $21.5M.
  • Banque Pictet & Cie added most to Medline Inc in Q2 2026, an estimated $237M increase.
  • Banque Pictet & Cie's biggest Q2 2026 reduction was Alphabet (Google) Class C, cutting an estimated $96.4M.
  • Banque Pictet & Cie fully exited Global X Artificial Intelligence & Technology ETF in Q2 2026, selling an estimated $17.7M.
  • Banque Pictet & Cie's ten largest holdings make up 66% of its $16B portfolio in Q2 2026.
  • Banque Pictet & Cie opened 22 new positions and closed 77 in Q2 2026.
  • Banque Pictet & Cie's portfolio value rose 13% quarter-over-quarter to $16B.

Based on Banque Pictet & Cie's 13F filing for Q2 2026, filed 24 Jul 2026.